The effect of changes in depression on health related quality of life (HRQoL) in HIV infection

General Hospital Psychiatry

Volumn 24, Issue 1, 2002, Pages 43-47

  Elliott, Andrew J ^a   Russo, Joan ^a   Roy Byrne, Peter P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AIDS; Antidepressant therapy; Health related quality of life; HIV; Major depression; Psychosocial functioning

Indexed keywords

ANTIVIRUS AGENT; IMIPRAMINE; PAROXETINE;

ADJUSTMENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIDEPRESSIVE AGENTS; ANTIGENS, CD4; DEPRESSIVE DISORDER, MAJOR; HIV SEROPOSITIVITY; HUMANS; MALE; PAROXETINE; PERSONAL SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SOCIAL ADJUSTMENT;

EID: 0036157491     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(01)00174-8     Document Type: Article

References (27)

1. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter
2. Effects of cognitive-behavioral therapy interventions on quality of life in persons with HIV
3. Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection
4. Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients. Istituto Superiore di Sanita 047 Study
5. Quality of life in asymptomatic and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy
6. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study
7. Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study
8. The role of personality, coping style and social support in health-related quality of life in HIV infection
9. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection
10. A randomized placebo-controlled trial of paroxetine versus imipramine in depressed HIV positive outpatients
11. The brief symptom inventory: An introductory report
12. Development of a rating scale for primary depressive illness
13. The assessment of anxiety
14. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)
15. Construct validities of the quality of well-being scale and the MOS-HIV-34 health survey for HIV-infected patients
16. Use of the MQoL-HIV with asymptomatic HIV-positive patients
17. Evaluation of a modified self-report measure of social adjustment
18. Quality of life enjoyment and satisfaction questionnaire: A new measure
19. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression
20. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes
21. Revision of the CDC surveillance case definition for HIV
22. Application of random effects models and other methods to the analysis of multidimensional quality of life data in an AIDS clinical trial
23. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS
24. Quality-of-life assessment in clinical research: Application in diverse populations
25. Quality of life assessment comes of age in the era of highly active antiretroviral therapy